16523250

Source:http://linkedlifedata.com/resource/pubmed/id/16523250

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008059, umls-concept:C0012734, umls-concept:C0036043, umls-concept:C0073393, umls-concept:C0231448, umls-concept:C0443252, umls-concept:C1274040, umls-concept:C2603343
pubmed:issue	2
pubmed:dateCreated	2006-3-8
pubmed:abstractText	The aim of this study was to assess the longterm efficacy, safety, and tolerability of risperidone, over a cumulative period of 3 years, in treating children with disruptive behaviour disorders and below average intelligence (IQ 35-84).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9212296
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Risperidone
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1018-8827
pubmed:author	pubmed-author:AugustynsIlseI, pubmed-author:CsabaKrisztinaK, pubmed-author:EerdekensMarielleM, pubmed-author:OlahRozaR, pubmed-author:ReyesMagaliM
pubmed:issnType	Print
pubmed:volume	15
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	97-104
pubmed:meshHeading	pubmed-meshheading:16523250-Adolescent, pubmed-meshheading:16523250-Attention Deficit and Disruptive Behavior Disorders, pubmed-meshheading:16523250-Body Mass Index, pubmed-meshheading:16523250-Child, pubmed-meshheading:16523250-Diagnostic and Statistical Manual of Mental Disorders, pubmed-meshheading:16523250-Drug Administration Schedule, pubmed-meshheading:16523250-Female, pubmed-meshheading:16523250-Humans, pubmed-meshheading:16523250-Male, pubmed-meshheading:16523250-Obesity, pubmed-meshheading:16523250-Risperidone, pubmed-meshheading:16523250-Time Factors, pubmed-meshheading:16523250-Treatment Outcome
pubmed:year	2006
pubmed:articleTitle	Long-term safety and efficacy of risperidone in children with disruptive behaviour disorders. Results of a 2-year extension study.
pubmed:affiliation	Johnson and Johnson Pharmaceutical Research and Development, 1125 Trenton-Harbourton Road, Titusville, NJ 08530, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Multicenter Study